Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5773-5781

  Meyer, A L ^a   Benson, J ^a   Song, F ^a   Javed, N ^a   Gienapp, I E ^a   Goverman, J ^a   Brabb, T A ^a   Hood, L ^a   Whitacre, C C ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LAMINA PROPRIA; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0035340263     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5773     Document Type: Article

References (64)

1. Experimental disseminated encephalomyelitis in white mice
2. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse
3. Delayed, relapsing experimental allergic encephalomyelitis in mice
4. 1 mice by myelin basic protein and its peptides: Localization of a second encephalitogenic determinant
5. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein
6. Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosis
7. Treatment of autoimmune encephalomyelitis with an antibody to T cell receptor β-chain
8. The T-cell receptor repertoire and autoimmune diseases
9. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy
10. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
11. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
12. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis
13. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
14. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
15. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
16. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis
17. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy
18. Oral tolerance in experimental autoimmune encephalomyelitis: Serum and salivary antibody responses
19. Oral tolerance in EAE: Reversal of tolerance by T helper cell cytokines
20. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis
21. Direct measurement of anergy of antigen specific T cells following oral tolerance induction
22. T cell activation and receptor down-modulation precede deletion induced by orally administered antigen
23. Peripheral deletion of antigen-reactive T cells in oral tolerance
24. Effects of oral antigen in T-cell receptor transgenic mice
25. + T lymphocytes
26. Antigen-driven bystander suppression after oral administration of antigens
27. + cells mediate active suppression
28. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
29. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells
30. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
31. Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols
32. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen
33. Large-scale preparation of myelin basic protein from central nervous tissue of several mammalian species
34. Studies on the species variability of experimental allergic encephalomyelitis in guinea pigs and rats
35. Antigen presentation by epithelial cells of the small intestine. II. Selective induction of suppressor T cells
36. Evidence for function of a la molecule on gut epithelial cells in man
37. + T cells
38. Differential regulation of B7 mRNA in enterocytes and lymphoid cells
39. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
40. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch
41. Expanding dendritic cells in vivo enhances the induction of oral tolerance
42. Visualizing the T-cell response elicited by oral administration of soluble protein antigen
43. Oral tolerance to haptens: Intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro
44. Endopeptidase inhibition and intestinal antigen processing in mice
45. Partial characterization of a circulating tolerogenic moiety which, after a feed of ovalbumin, suppresses delayed-type hypersensitivity in recipient mice
46. The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice
47. Lymphocyte homing and homeostasis
48. The anatomical basis of intestinal immunity
49. The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: Association between aberrant presentation in the lamina propria and oral tolerance
50. Strange brew: T cells in the liver
51. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats
52. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding
53. Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction
54. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis
55. Enhancement of experimental allergic enephalomyelitis in mice by antibodies against IFN-γ
56. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse
57. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system
58. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice
59. + T cells
60. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide
61. + T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice
62. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
63. + T cells that prevent spontaneous autoimmune encephalomyelitis
64. Antigen-specific T cell activation and proliferation during oral tolerance induction